Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Neural Basis of Frontotemporal Degeneration and Related Disorders

Start: July 1, 2003
End: July 2020
Enrollment: 500

What Is This Study About?

This observational study aims to better understand the causes of frontotemporal degeneration (FTD), multiple systems atrophy (MSA), and progressive supranuclear palsy (PSP) to help improve diagnosis and develop future treatments.

Do I Qualify To Participate in This Study?

Minimum Age: 18 Years

Maximum Age: N/A

Must have:

  • Diagnosis of FTD, PSP, or MSA

Must NOT have:

  • Pacemaker or certain metallic implants
  • Pregnant

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: University of Pennsylvania

Source: ClinicalTrials.gov ID: NCT03452956

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health